Title:
改変バクテリオファージ
Document Type and Number:
Japanese Patent JP7051809
Kind Code:
B2
Abstract:
A modified bacteriophage capable of infecting a target bacterium, which bacteriophage comprises bacteriophage Phi33 and includes a toxin gene encoding a toxin protein which is toxic to the target bacteria; wherein the bacteriophage is lytic.
More Like This:
| WO/1996/012027 | METHOD OF PRODUCING A CHIMERIC PROTEIN |
| WO/2019/237380 | LENTIVIRUS-BASED CRISPR/CPF1 GENE EDITING VECTOR AND APPLICATION THEREOF |
| JP2023060000 | RETROVIRAL AND LENTIVIRAL VECTORS |
Inventors:
Heather fairhead
Adam Wilkinson
Adam Wilkinson
Application Number:
JP2019503776A
Publication Date:
April 11, 2022
Filing Date:
April 07, 2017
Export Citation:
Assignee:
Phyco Therapeutics Limited
International Classes:
C12N7/01; A61K9/12; A61K35/76; A61K38/00; A61K48/00; A61P31/04
Domestic Patent References:
| JP2010535482A |
Foreign References:
| WO2010141135A2 | ||||
| US20150064770 |
Other References:
J. Biotechnol.,2005年,vol.115, p.101-107
PLOS ONE,2013年,vol.8, no.7, e68562
PLOS ONE,2013年,vol.8, no.7, e68562
Attorney, Agent or Firm:
Koichi Hirota
Yoshihiro Ryu
Naoko Matsuda
Yoshihiro Ryu
Naoko Matsuda